1. Boubenider S, Hiesse C, Goupy C, et al (1997) Incidence and consequences of post-transplantation lymphoproliferative disorders. J Nephrol 10:136–145
2. Goral S, Felgar R, Shappell S (1997) Posttransplantation lymphoproliferative disorder in a renal allograft recipient. Am J Kidney Dis 30:301–307
3. Kew CE II, Lopez-Ben R, Smith JK (2000) Post-transplant lymphoproliferative disorder localized near the allograft in renal transplantation. Transplantation 69:809–814
4. Walker RC, Paya CV, Marshall WF, et al (1995) Pretransplantation seronegative Epstein-Barr virus status is the primary risk factor of posttransplantation lymphoproliferative disorder in adult heart, lung, and other solid organ transplantations. J Heart Lung Transplant 14:214–221
5. Swinnen LJ, Costanzo-Nordin MR, Fisher SG, et al (1990) Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac-transplant recipients. N Engl J Med 323:1723–1728